Kintara Therapeutics Shares Rise 29% After Orphan Drug Designation for VAL-083
By Chris Wack Kintara Therapeutics Inc. shares were up 29% to $10.35 on Thursday after the company said it received an orphan drug designation from the Food and Drug Administration for... | December 15, 2022
Source: marketscreener.com